Variant report
Variant | nsv599494 |
---|---|
Chromosome Location | chr5:117371148-117393156 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557999760 | chr5:117378607-117378608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs374947374 | chr5:117378608-117378609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs192635945 | chr5:117378619-117378620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72771498 | chr5:117378639-117378640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs13159036 | chr5:117378643-117378644 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs573362112 | chr5:117378709-117378710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542389067 | chr5:117378729-117378730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555975511 | chr5:117378751-117378752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575827198 | chr5:117378777-117378778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544494344 | chr5:117378795-117378796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529923621 | chr5:117378813-117378814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566390553 | chr5:117378847-117378848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145242285 | chr5:117378859-117378860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548618240 | chr5:117378891-117378892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535943888 | chr5:117378941-117378942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540214500 | chr5:117378944-117378945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147612131 | chr5:117378949-117378950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185107388 | chr5:117378973-117378974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548704299 | chr5:117379016-117379017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568628700 | chr5:117379022-117379023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11367045 | chr5:117379067-117379068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114493027 | chr5:117379077-117379078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575749979 | chr5:117379151-117379152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539995834 | chr5:117379160-117379161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190086084 | chr5:117379249-117379250 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571476157 | chr5:117379272-117379273 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs11463920 | chr5:117379310-117379311 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs376773683 | chr5:117379312-117379313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs140027001 | chr5:117379387-117379388 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553399617 | chr5:117379412-117379413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145426675 | chr5:117379419-117379420 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573625475 | chr5:117379426-117379427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535935385 | chr5:117379437-117379438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555862983 | chr5:117379501-117379502 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115565139 | chr5:117379518-117379519 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145212679 | chr5:117379524-117379525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558109843 | chr5:117379526-117379527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs578195054 | chr5:117379528-117379529 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375495168 | chr5:117379555-117379556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540906345 | chr5:117379613-117379614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540554853 | chr5:117379642-117379643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149142702 | chr5:117379656-117379657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs11746491 | chr5:117379681-117379682 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs573945707 | chr5:117379689-117379690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181163219 | chr5:117379763-117379764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184692493 | chr5:117379769-117379770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562555518 | chr5:117379785-117379786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs531313955 | chr5:117379786-117379787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544401837 | chr5:117379791-117379792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143223219 | chr5:117379816-117379817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22543975 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:117378600-117379200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr5:117378800-117381000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr5:117379200-117379600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr5:117379200-117381000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr5:117379600-117380000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr5:117379600-117381200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr5:117379600-117381200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr5:117379600-117381200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr5:117380000-117380400 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
10 | chr5:117380200-117381000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr5:117380200-117381000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr5:117380800-117381200 | Enhancers | H1 Cell Line | embryonic stem cell |